Siemens offers liver fibrosis blood test in U.S.

By staff writers

November 26, 2019 -- Siemens Healthineers said it is now providing its Enhanced Liver Fibrosis (ELF) testing service in 49 U.S. states, Washington, DC, and Puerto Rico.

Siemens' ELF test analyzes quantitative measurements taken from a patient's blood sample for three markers of liver fibrosis: hyaluronic acid (HA), amino-terminal propeptide of type III procollagen (PIIINP), and tissue inhibitor of metalloproteinase 1 (TIMP-1).

The algorithm generates a score that can help identify patients with chronic liver disease, including nonalcoholic fatty liver disease, and stratify these patients' risk of developing adverse liver-related events, according to Siemens.

Siemens overcomes lagging Diagnostics numbers in Q4
Despite lagging performance in its Diagnostics business, Siemens Healthineers posted strong overall financial results for its fourth quarter, with revenue...
Profitability dips at Siemens Diagnostics, division chief to leave
Siemens Healthineers saw profit decline at its Diagnostics unit for the third quarter, as the company experienced issues related to the ramp-up of its...
Siemens builds on diabetes testing
Siemens Healthineers has released a hemoglobin A1c test that it believes will help clinicians diagnose and monitor patients with diabetes evaluated with...

Copyright © 2019

Last Updated np 11/25/2019 6:06:10 PM